As blockchain technology and cryptocurrency continue to break through the boundaries of traditional industries, BIO Protocol, as a pioneer in the field of decentralized science (DeSci), is redefining the way scientific research and biotechnology are financed, developed, and intellectual property managed. By combining blockchain and biotechnology, BIO Protocol not only breaks the traditional scientific funding model, but also strives to open up a new path for scientific innovation and create a more open, transparent, and collaborative scientific research environment.
BIO Protocol's Core Mission and Innovation
BIO Protocol aims to promote the rapid development of biotechnology through decentralized mechanisms, especially in the management and commercialization of biological research and intellectual property. Its core goal is to enable global patients, scientists and biotech experts to jointly fund, build and own tokenized biotechnology projects and intellectual property (IP), thereby accelerating the innovation process.
Key features of the BIO protocol include:
Decentralized Funding and Incentives: Through BIO tokens, users can participate in funding new BioDAOs (decentralized autonomous organizations), receive IP tokens and priority investment opportunities.
Global collaboration and resource sharing: Using a decentralized approach, scientists, patients, and biotech experts can collaborate efficiently, share data, capital, and labor, and accelerate breakthroughs in biotechnology.
Liquidity and Market Access: BIO supports the financing and development of projects through a decentralized liquidity pool, providing participants with high-quality investment opportunities.
What is BioDAO?
BioDAO is a decentralized scientific research community focused on a specific area of medicine or biotechnology. By bringing together global participants - including patients, scientists, investors and technical experts - BioDAO is able to jointly advance scientific research, reduce the cost of innovation and accelerate commercialization.
Each BioDAO raises funds through token sales to develop intellectual property (IP) related to its field. These IPs not only provide potential income for members, but can also be managed, licensed and traded in a tokenized form. Compared with traditional scientific models, BioDAO provides multiple advantages such as capital efficiency, flexibility, shared IP ownership, open access and diversified investment.
Five core operations of the BIO protocol
Curation and community participation: BIO token holders can participate in the curation of BioDAO by staking tokens, deciding which new DAOs can join the BIO protocol network. This mechanism ensures community participation and support, and increases trust and transparency in scientific research projects.
Funding: If a BioDAO is selected to join the BIO Protocol, BIO token holders will have the opportunity to participate in the DAO's funding, token auctions, and seed round investments. This provides financial support for early biotech projects and allows participants to benefit from the project's early stages.
Liquidity and Market Participation: The BIO Protocol reduces the complexity of liquidity management by providing secondary market liquidity for BioDAO. BIO tokens will be used as the basis of liquidity pools along with BioDAO tokens and other assets to facilitate transactions and capital flows.
Bio/Acc Rewards: Through a rewards mechanism, the BIO protocol incentivizes BioDAO and its members to complete key milestones, such as funding on-chain science, achieving IP development, or releasing consumer products with revenue. These rewards can be directly returned to participants, further driving the growth of the entire network.
Meta-Governance: The BIO protocol is not just a funding and liquidity platform, it also provides governance power to BIO token holders. This means that users can participate in the decision-making process of multiple BioDAOs within the BIO network and drive the development of the entire ecosystem.
Success Story: Practical Application of BIO Protocol
VitaDAO: Dedicated to the science of longevity, it has received over $5 million in funding, received support from Pfizer Ventures, and is working with Newcastle University.
HairDAO: Focuses on treating hair loss, owns the DAO patent and the consumer product Follicool, attracting a wide range of investors and users.
CerebrumDAO: Focused on brain health research, it raised over $1.5 million and reached an agreement with Fission Pharma to advance research into neurodegenerative diseases.
ValleyDAO: dedicated to synthetic biology, raised over $2 million and partnered with Imperial College London to advance research in gene editing and cell engineering.
AthenaDAO: Focused on women’s health, funded $500K for translational research, with multiple IP deals underway.
Token Economics and Governance
BIO tokens are the core governance tokens of the BIO protocol, through which holders can participate in the funding and decision-making of scientific research. The total supply is 3.32 billion, and BIO tokens will be distributed at genesis as follows:
Community: 56%
Community auction: 20%
Community airdrop: 6%
Ecosystem incentives: 25%
Molecule Ecosystem Fund: 5%
Investors: 13.6%
Core Contributors: 21.2%
Consultant: 4.2%
BIO Protocol drives the future of decentralized science
BIO Protocol represents the future of scientific research and biotechnology development. It is not only a blockchain financial protocol, but also a decentralized scientific community that is changing the traditional scientific research model through blockchain technology, DAO and tokenized assets. The success of BIO Protocol will provide a more open, transparent and efficient platform for scientists, patients, investors and technical experts around the world, promoting innovation in biotechnology and further development of scientific research.
Are you interested in the BIO Protocol and Decentralized Science (DeSci)? How do you think this will impact future biotech research and investment opportunities? Feel free to share your thoughts in the comments!